Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Saavedra

Showing results (121-130 of 209) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|June 20, 1997
Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liverJ E Saavedra, T R Billiar, D L Williams, et al.
Scientific Reports|February 10, 2022
Microstrip sensor and methodology for the determination of complex anisotropic permittivity using perturbation techniquesHector-Noel Morales-Lovera, Jose-Luis Olvera-Cervantes, Aldo-Eleazar Perez-Ramos, et al.
Journal of Natural Products|July 25, 1998
A new antitubercular mulinane diterpenoid from Azorella madreporica ClosG A Wächter, S G Franzblau, G Montenegro, et al.
Chemico-Biological Interactions|May 31, 2011
Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1Wei Qu, Lida Cheng, Anna L Dill, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2017
The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiationMax Heckler, Nadja Osterberg, Jessica Guenzle, et al.
Bioorganic & Medicinal Chemistry|October 22, 2008
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsHarinath Chakrapani, Ravi C Kalathur, Anna E Maciag, et al.
Bioorganic & Medicinal Chemistry|June 6, 2015
PABA/NO lead optimization: Improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cellsYouseung Kim, Anna E Maciag, Zhao Cao, et al.
Nitric Oxide : Biology and Chemistry|March 3, 2005
The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular levelWei Qu, Jie Liu, Richard Fuquay, et al.
Nitric Oxide : Biology and Chemistry|March 21, 2006
Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450Keiko Inami, Raymond W Nims, Aloka Srinivasan, et al.
Revista Medica De Chile|September 1, 1996
[Cardiovascular risk factors in 15 patients in chronic hemodialysis in Temuco city. Descriptive comparison with the general Chilean population]P Montecinos, M Illesca, E Saavedra, et al.
Pageof 21

Showing results (121-130 of 209) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|June 20, 1997
Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liverJ E Saavedra, T R Billiar, D L Williams, et al.
Scientific Reports|February 10, 2022
Microstrip sensor and methodology for the determination of complex anisotropic permittivity using perturbation techniquesHector-Noel Morales-Lovera, Jose-Luis Olvera-Cervantes, Aldo-Eleazar Perez-Ramos, et al.
Journal of Natural Products|July 25, 1998
A new antitubercular mulinane diterpenoid from Azorella madreporica ClosG A Wächter, S G Franzblau, G Montenegro, et al.
Chemico-Biological Interactions|May 31, 2011
Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1Wei Qu, Lida Cheng, Anna L Dill, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2017
The nitric oxide donor JS-K sensitizes U87 glioma cells to repetitive irradiationMax Heckler, Nadja Osterberg, Jessica Guenzle, et al.
Bioorganic & Medicinal Chemistry|October 22, 2008
Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugsHarinath Chakrapani, Ravi C Kalathur, Anna E Maciag, et al.
Bioorganic & Medicinal Chemistry|June 6, 2015
PABA/NO lead optimization: Improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cellsYouseung Kim, Anna E Maciag, Zhao Cao, et al.
Nitric Oxide : Biology and Chemistry|March 3, 2005
The nitric oxide prodrug, V-PYRRO/NO, protects against cadmium toxicity and apoptosis at the cellular levelWei Qu, Jie Liu, Richard Fuquay, et al.
Nitric Oxide : Biology and Chemistry|March 21, 2006
Metabolism of a liver-selective nitric oxide-releasing agent, V-PYRRO/NO, by human microsomal cytochromes P450Keiko Inami, Raymond W Nims, Aloka Srinivasan, et al.
Revista Medica De Chile|September 1, 1996
[Cardiovascular risk factors in 15 patients in chronic hemodialysis in Temuco city. Descriptive comparison with the general Chilean population]P Montecinos, M Illesca, E Saavedra, et al.
Pageof 21